Home/Filings/4/0000950170-23-031702
4//SEC Filing

Ros Matthew 4

Accession 0000950170-23-031702

CIK 0001622229other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:53 PM ET

Size

5.6 KB

Accession

0000950170-23-031702

Insider Transaction Report

Form 4
Period: 2023-07-03
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-07-03+1,7431,743 total
    Exercise: $11.96From: 2023-07-03Exp: 2033-07-03Common Stock (1,743 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Documents

1 file

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001673802

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:53 PM ET
Size
5.6 KB